Skip to main navigation Skip to search Skip to main content

Mannosamine-Engineered Nanoparticles for Precision Rifapentine Delivery to Macrophages: Advancing Targeted Therapy Against Mycobacterium Tuberculosis

Press/Media

Period19 Mar 2025

Media coverage

1

Media coverage

  • TitleMannosamine-Engineered Nanoparticles for Precision Rifapentine Delivery to Macrophages: Advancing Targeted Therapy Against Mycobacterium Tuberculosis
    Media name/outletDove Medical Press
    Date19/03/25
    PersonsYasuhiro TANAKA